A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis.

By S. J. Cowell, D. Newby, R. Prescott, P. Bloomfield, J. Reid, D. Northridge, N. Boon. New England Journal of Medicine, 2005

1,087 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/a7dabf2abec9c56801a168dd955642653c3e9aa0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. I. Graham

In Pulmonary and Respiratory Medicine

1. I. Graham

In Surgery

1. I. Graham

Citations in the corpus

• 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. (2016, background): “100,131 Secondary targets have also been defined by inference for nonHDL-C and for apoB; they receive a moderate grading, as they have not been extensively studied in RCTs. Clinicians who are using apoB in their practice can use targets levels of <100 mg/dL and <80 mg/ dL for subjects at high or at ”